Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits May 17, 2016
Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression May 12, 2016
Glutamate and GABA Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine May 12, 2016
Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial April 19, 2016
Ketamine for Treatment-Resistant Unipolar and Bipolar Major Depression: Critical Review and Implications for Clinical Practice April 6, 2016
Ketamine for treatment-resistant depression: recent developments and clinical applications April 6, 2016
